Results 111 to 120 of about 12,410 (287)
Denosumab-induced hypocalcaemia in metastatic gastric cancer [PDF]
\ua9 Author(s) (or their employer(s)) 2024. Hypocalcaemia in malignancy is infrequently reported and the underlying cause is often multifactorial. Denosumab, an antiresorptive medication, can be used to treat a number of cancer-related complications ...
Wakefield D, Quinton R, Gouldthorpe C
core
Introduction: Chronic kidney disease-mineral and bone disease (CKD-MBD) is a complication of chronic kidney disease (CKD) involving derangements in serum calcium and phosphate.
Mei Hui Amanda Yong +4 more
doaj +1 more source
Hypomagnesaemia and hypocalcaemia in a patient with ovarian carcinoma [PDF]
Graham Leese, R. T. Jung, M C Browning
openalex +1 more source
Hypocalcaemia as an important differential diagnosis in patients suffering from stridor following thyroidectomy [PDF]
Christine Nitschke +3 more
openalex +1 more source
Rare cause of persistent hypocalcaemia in infancy due to PTH gene mutation [PDF]
Savita Khadse +3 more
openalex +1 more source
Multiple Oral and Eyelid Nodules in a Pediatric Patient
Oral Diseases, EarlyView.
Caique Mariano Pedroso +10 more
wiley +1 more source
This original research used medication administration data to explore adherence to treatment guidelines for the most common osteoporosis medications in long‐term residential aged care (RAC) in Australia. The paper highlights gaps in adherence to treatment guidelines that must be addressed to improve outcomes of older adults living in RAC.
Marea O'Donnell +7 more
wiley +1 more source
Hypocalcaemia Secondary to Iatrogenic Hypoparathyroidism as a Rare Cause of Dilated Cardiomyopathy [PDF]
Postoperative hypocalcaemia caused by hypoparathyroidism is one of the most common morbidities of total thyroidectomy. Hypoparathyroidism is associated with chronic hypocalcaemia which can have a variety of manifestations including cardiovascular changes.
Elhadi, NazikElmalika Hayder +1 more
core +1 more source
Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancer
Medullary thyroid cancer (MTC) is a rare subtype of thyroid cancer originating from parafollicular C-cells of the thyroid. Tyrosine kinase inhibitors are used to treat patients with advanced MTC.
Leslie Cheng +7 more
doaj +1 more source

